Journal of Clinical Endocrinology & Metabolism, Vol 66, 444-446, Copyright © 1988 by Endocrine Society

ARTICLES

Estrogen-induced prolactinoma in a man

LJ Gooren, J Assies, H Asscheman, R de Slegte and H van Kessel
Department of Endocrinology/Andrology, Academic Hospital Vrije Universiteit, Amsterdam, The Netherlands.

Prolactinomas can be induced in rats by large doses of estrogens. Whether prolactinomas can be induced in humans by estrogens, however, is not known. This report describes the development of a prolactinoma in a man with previously normal plasma PRL levels after the administration of pharmacological doses of estrogen. The patient, a 26- yr-old male to female transsexual, took cyproterone acetate (100 mg/day, orally) and ethinyl estradiol (100 micrograms/day, orally) for 10 months and (surrepititiously) estradiol-17-undecanoate (100 mg, twice weekly, im) for about 6 of the 10 months. Plasma PRL levels rose from 0.05 to 5.20 U/L within 10 months (normal, 0.05-0.30 U/L). A computed tomographic scan showed a pituitary mass with suprasellar extension. After all estrogen therapy was discontinued, his plasma estradiol levels gradually declined from 2.8 to 0.77 nmol/L (normal, 0.04-0.12 nmol/L), but PRL levels rose further to 6.2 U/L. Bromocriptine treatment (2.5 mg twice daily) then was given. Plasma PRL fell gradually to 0.43 U/L and a computed tomographic scan after 5 months showed reduction in tumor size. The patient then discontinued bromocriptine treatment. Four months later his plasma estradiol level was normal, while plasma PRL had risen to 4.6 U/L, indicating autonomous PRL secretion. We conclude that 1) estrogen in pharmacological doses can induce prolactinomas in man; and 2) subjects treated with high doses of estrogen must, therefore, be surveyed for the development of such tumors.

This article has been cited by other articles:

				A. Mueller and L. Gooren Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones Eur. J. Endocrinol., September 1, 2008; 159(3): 197 - 202. [Abstract] [Full Text] [PDF]

				L. J. Gooren, E. J. Giltay, and M. C. Bunck Long-Term Treatment of Transsexuals with Cross-Sex Hormones: Extensive Personal Experience J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 19 - 25. [Abstract] [Full Text] [PDF]

				N. Tugnet, J. C. Goddard, R. M Vickery, D. Khoosal, and T. R Terry Current management of male-to-female gender identity disorder in the UK Postgrad. Med. J., October 1, 2007; 83(984): 638 - 642. [Abstract] [Full Text] [PDF]

				A. Mueller, F. Kiesewetter, H. Binder, M. W. Beckmann, and R. Dittrich Long-Term Administration of Testosterone Undecanoate Every 3 Months for Testosterone Supplementation in Female-to-Male Transsexuals J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3470 - 3475. [Abstract] [Full Text] [PDF]

				A. J Sarkar, K. Chaturvedi, C. P. Chen, and D. K Sarkar Changes in thrombospondin-1 levels in the endothelial cells of the anterior pituitary during estrogen-induced prolactin-secreting pituitary tumors J. Endocrinol., February 1, 2007; 192(2): 395 - 403. [Abstract] [Full Text] [PDF]

				M. P. Gillam, M. E. Molitch, G. Lombardi, and A. Colao Advances in the Treatment of Prolactinomas Endocr. Rev., August 1, 2006; 27(5): 485 - 534. [Abstract] [Full Text] [PDF]

				L A Nolan and A Levy The effects of testosterone and oestrogen on gonadectomised and intact male rat anterior pituitary mitotic and apoptotic activity. J. Endocrinol., March 1, 2006; 188(3): 387 - 396. [Abstract] [Full Text] [PDF]

				K. Chaturvedi and D. K. Sarkar Role of Protein Kinase C-Ras-MAPK p44/42 in Ethanol and Transforming Growth Factor-{beta}3-Induced Basic Fibroblast Growth Factor Release from Folliculostellate Cells J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1346 - 1352. [Abstract] [Full Text] [PDF]

				T. E. Strecker, T. J. Spady, B. S. Schaffer, K. A. Gould, A. E. Kaufman, F. Shen, M. T. McLaughlin, K. L. Pennington, J. L. Meza, and J. D. Shull Genetic Bases of Estrogen-Induced Pituitary Tumorigenesis: Identification of Genetic Loci Determining Estrogen-Induced Pituitary Growth in Reciprocal Crosses Between the ACI and Copenhagen Rat Strains Genetics, April 1, 2005; 169(4): 2189 - 2197. [Abstract] [Full Text] [PDF]

				S. Oomizu, K. Chaturvedi, and D. K. Sarkar Folliculostellate Cells Determine the Susceptibility of Lactotropes to Estradiol's Mitogenic Action Endocrinology, March 1, 2004; 145(3): 1473 - 1480. [Abstract] [Full Text] [PDF]

				K. Chaturvedi and D. K. Sarkar Involvement of Protein Kinase C-Dependent Mitogen-Activated Protein Kinase p44/42 Signaling Pathway for Cross-Talk between Estradiol and Transforming Growth Factor-{beta}3 in Increasing Basic Fibroblast Growth Factor in Folliculostellate Cells Endocrinology, February 1, 2004; 145(2): 706 - 715. [Abstract] [Full Text] [PDF]

				E. Moore, A. Wisniewski, and A. Dobs Endocrine Treatment of Transsexual People: A Review of Treatment Regimens, Outcomes, and Adverse Effects J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3467 - 3473. [Abstract] [Full Text] [PDF]

				M. P. Gillam, S. Middler, D. J. Freed, and M. E. Molitch The Novel Use of Very High Doses of Cabergoline and a Combination of Testosterone and an Aromatase Inhibitor in the Treatment of a Giant Prolactinoma J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4447 - 4451. [Abstract] [Full Text] [PDF]

				F. J. Hayes and J. H. Eichhorn Case 12-2000- A 60-Year-Old Man with Persistent Gynecomastia after Excision of a Pituitary Adenoma N. Engl. J. Med., April 20, 2000; 342(16): 1196 - 1204. [Full Text] [PDF]

				T. J. Spady, K. L. Pennington, R. D. McComb, and J. D. Shull Genetic Bases of Estrogen-Induced Pituitary Growth in an Intercross between the ACI and Copenhagen Rat Strains: Dominant Mendelian Inheritance of the ACI Phenotype Endocrinology, June 1, 1999; 140(6): 2828 - 2835. [Abstract] [Full Text]

				V. L. Green, V. Speirs, A. M. Landolt, P. M. Foy, and S. L. Atkin 17{beta}-Hydroxysteroid Dehydrogenase Type 1, 2, 3, and 4 Expression and Enzyme Activity in Human Anterior Pituitary Adenomas J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1340 - 1345. [Abstract] [Full Text]

				U. Fahy, M.I. Hopton, M. Hartog, C.H. Bolton, and M.G.R. Hull The lipoprotein profile of women with hyperprolactinaemic amenorrhoea Hum. Reprod., February 1, 1999; 14(2): 285 - 287. [Abstract] [Full Text] [PDF]

				D. Wynick, C. J. Small, A. Bacon, F. E. Holmes, M. Norman, C. J. Ormandy, E. Kilic, N. C. H. Kerr, M. Ghatei, F. Talamantes, et al. Galanin regulates prolactin release and lactotroph proliferation PNAS, October 13, 1998; 95(21): 12671 - 12676. [Abstract] [Full Text] [PDF]